Inhibition of VEGFR2 has been shown to improve endothelial cell inactivation in tumors and increase the migration of CTLs to tumors, demonstrating that the main determinant of endothelial cell inactivation is suggested to be VEGFR2 in tumor vessel endothelial cells [34]. Here, KDR is linked to neoplasm.